The FDA’s effort to expedite reviews for drugs in line with the Trump administration’s priorities was greeted warmly by a pharmaceutical industry interested in moving approvals more quickly, but raised concerns about the scope of the plan in light of recent cuts at the agency.

The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive for drugmakers to develop biosimilar medicines, the copycat versions of off-patent biologic drugs.

Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for menopause-related hot flashes and night sweats.

The FDA is planning to speed approvals of highly similar copies of expensive biologic drugs, the latest effort in President Donald Trump’s aggressive agenda to lower costs for medicines in the US.

Health and Human Services Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary will give remarks on the Trump administration’s push to lower drug

More parents are asking with autistic children are asking to prescribe leucovorin despite a lack of data about its benefits

Texas Attorney General Ken Paxton alleged Johnson & Johnson deceptively marketed the drug as safe for pregnant Texans.

A federal judge is set to decide whether the Trump administration will have to find funds to keep SNAP benefits flowing. And, President Trump says the U.S. should resume nuclear weapons testing.

The U.S. Food & Drug Administration (FDA) has announced a recall of a select lot of Moonlight Companies peaches because they may be contaminated with Listeria monocytogenes. The recall impacts certain California-grown yellow and white peaches sold at retail stores, including Sam’s Club, Walmart, Kroger, and Trader Joe’s nationwide.